Literature DB >> 6325156

Human papillomavirus 1a complete DNA sequence: a novel type of genome organization among papovaviridae.

O Danos, M Katinka, M Yaniv.   

Abstract

The complete nucleotide sequence of human papillomavirus type 1a (7811 nucleotides) has been established. The overall organization of the viral genome is different from that of other related papovaviruses (SV40, BKV, polyoma). Firstly, genetic information seems to be coded by one strand. Secondly, no significant homology is found with SV40 or polyoma coding sequence for either DNA or deducted protein sequences. The relatedness of human and bovine papillomaviruses is revealed by a conserved coding sequence in the two species. Two regions can be defined on the viral genome: the putative early region contains two large open reading frames of 1446 and 966 nucleotides, together with several split ones, and corresponds to the transforming part of the bovine papillomavirus type 1 genome, and the remaining sequences, which include two open reading frames likely to encode structural polypeptide(s). The DNA sequence is analysed and putative signals for regulation of gene expression, and homologies with the Alu family of human ubiquitous repeats and the SV40 72-bp repeat are outlines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6325156      PMCID: PMC553025          DOI: 10.1002/j.1460-2075.1982.tb01152.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  The asymmetric segregation of parental nucleosomes during chrosome replication.

Authors:  M M Seidman; A J Levine; H Weintraub
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

Review 2.  Molecular biology of papovaviruses.

Authors:  G C Fareed; D Davoli
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Inverted repetitive sequences in human papilloma virus 1 (HPV-1) DNA.

Authors:  L Gissmann; H zur Hausen
Journal:  Virology       Date:  1977-12       Impact factor: 3.616

Review 4.  Nucleic acids of tumor viruses.

Authors:  L V Crawford
Journal:  Adv Virus Res       Date:  1969       Impact factor: 9.937

5.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

6.  Codon catalog usage is a genome strategy modulated for gene expressivity.

Authors:  R Grantham; C Gautier; M Gouy; M Jacobzone; R Mercier
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

7.  Human papillomavirus DNA: physical mapping of the cleavage sites of Bacillus amyloliquefaciens (BamI) and Haemophilus parainfluenzae (HpaII) endonucleases and evidence for partial heterogeneity.

Authors:  M Favre; G Orth; O Croissant; M Yaniv
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

8.  Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses.

Authors:  M Favre; F Breitburd; O Croissant; G Orth
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

9.  Fractionation of the sequence organization of human DNA by preparative HgCl2/Cs2SO4 density gradients.

Authors:  F P Rinehart; V L Wilson; C W Schmid
Journal:  Biochim Biophys Acta       Date:  1977-01-03

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  83 in total

1.  General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions.

Authors:  A J van den Brule; P J Snijders; P M Raaphorst; H F Schrijnemakers; H Delius; L Gissmann; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

Review 2.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Messenger RNAs from the E1 region of bovine papillomavirus type 1 detected in virus-infected bovine cells.

Authors:  S Burnett; J Moreno-Lopez; U Pettersson
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

Review 4.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  A highly conserved nucleotide string shared by all genomes of human papillomaviruses.

Authors:  J Campione-Piccardo; M L Montpetit; L Grégoire; M Arella
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

6.  Conserved features in papillomavirus and polyomavirus capsids.

Authors:  D M Belnap; N H Olson; N M Cladel; W W Newcomb; J C Brown; J W Kreider; N D Christensen; T S Baker
Journal:  J Mol Biol       Date:  1996-06-07       Impact factor: 5.469

Review 7.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

8.  Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3' untranslated region of human papillomavirus type 1 late mRNAs.

Authors:  C Zhao; W Tan; M Sokolowski; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Human papillomavirus type 70 genome cloned from overlapping PCR products: complete nucleotide sequence and genomic organization.

Authors:  O Forslund; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.

Authors:  N Yaegashi; S A Jenison; J M Valentine; M Dunn; L B Taichman; D A Baker; D A Galloway
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.